HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter ended June 30, 2015.
Quarter ended June 30, 2015 Highlights - compared to June 30, 2014
•Net sales of $215 million, reflects an increase of $85 million. Last year’s quarter net sales were negatively impacted by a $79 million provision for price protection (current quarter’s price protection provision was $14 million).
Help employers find you! Check out all the jobs and post your resume.
